We are a specialized Contract Research Organization (CRO) dedicated to advancing preclinical research in the field of obesity. Drawing on our deep expertise and innovative approaches, we strive to deliver high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics.
Anti-Obesity Small Molecule Drug Development
From target validation to lead optimization, we provide a seamless pipeline to accelerate your small molecule obesity therapeutics.
Gene Therapy Development
Combining industry-leading expertise and state-of-the-art facilities, we enable the translation of innovative genetic approaches into viable obesity treatment solutions.
Cell Therapy Development
Recognizing the tremendous potential of cell-based therapies, we offer comprehensive support for the development of cutting-edge cell-based obesity treatments.
Antibody Therapy Development
Our robust antibody engineering capabilities and thorough preclinical assessment strategies empower the advancement of your next-generation antibody-based obesity therapies.
Tissue Engineering Therapy Development
Combining expertise in stem cell biology, biomaterial engineering, and 3D culture systems, we pioneer the development of innovative tissue-engineered obesity treatments.
Nanotherapy Development Service
Harnessing the unique properties of nanomaterials, our nanotherapy development service explores the potential of cutting-edge nanoparticle-based systems for targeted obesity treatment.
Driven by a passion for scientific innovation and a commitment to client success, we have established a reputation for delivering high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics.
Learn More +
Obesity Models
We offer a range of animal models that accurately replicate obesity-related conditions, providing crucial insights into the mechanisms of obesity and the efficacy of potential therapeutic interventions. These models serve as essential tools for studying disease progression and testing new obesity therapy.
Pharmacodynamic Study of Anti-Obesity Drugs
Our pharmacodynamic studies assess the biological effects and mechanisms of action of anti-obesity drugs in relevant models. By measuring parameters like weight loss, metabolism, and appetite regulation, we provide critical data to inform dosing strategies and therapeutic efficacy.
Pharmacokinetic Study of Anti-Obesity Drugs
We conduct comprehensive pharmacokinetic studies to evaluate the absorption, distribution, metabolism, and excretion of anti-obesity drugs. This information is vital for understanding drug behavior in the body and optimizing dosing regimens for maximum effectiveness.
Bioanalysis of Anti-Obesity Drugs
Our bioanalysis services utilize advanced techniques to quantify drug concentrations in biological samples, ensuring accurate assessment of drug exposure and efficacy. This data supports the evaluation of pharmacodynamics and safety outcomes in obesity research.
Safety Assessment of Anti-Obesity Drugs
We perform rigorous safety assessments to evaluate the potential risks and side effects of anti-obesity drugs in preclinical models. Our comprehensive safety studies are essential for identifying toxicological concerns and ensuring regulatory compliance prior to clinical trials.
Custom Services
We are here to assist you with any inquiries or support you may need regarding our services. Please feel free to reach out, and our team will be happy to help you find the solutions that best meet your needs.
November 7, 2025
December 26, 2025
October 15, 2025
November 7, 2025
Recognizing the multifaceted nature of obesity, we leverage our expertise in preclinical research to provide tailored solutions that address the unique challenges faced by our partners in the biotechnology and pharmaceutical industries.
Copyright © Protheragen. All rights reserves.
